Stay updated on Pembrolizumab for Meningioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.

Latest updates to the Pembrolizumab for Meningioma Clinical Trial page
- Check5 days agoChange DetectedRecent administrative updates were added to the study record, including revision dates 2026-06-18 and 2026-05-27, while earlier January 2026 dates were removed. This indicates the page has been refreshed with new revision timestamps rather than changes to trial information.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page now signals that recruitment is closed and adds new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), along with a formatting tweak ('Intervention/Treatment') and a version note ('Revision: v3.6.0').SummaryDifference0.4%

- Check19 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a new build or template update. No study data or content appears to be altered by this change.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating an administrative update to the page template. No substantive content or study data were changed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s interface revision/version label was updated from v3.5.2 to v3.5.3 without changing the underlying study details shown on the record.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.